医疗机器人公司Procept Biorobotics(PRCT.US)今日股价大涨5.44%,收于94.62美元/股,成交量较大。公司新发布的2024财年第三季度业绩报告显示营收和净利润均同比大幅增长,且超过预期,受此利好因素推动股价走高。
公司第三季度营收为5837万美元,同比大增66.3%,净利润虽然仍为亏损但亏损幅度较上年同期收窄14.83%至2097万美元。数据反映该公司在医疗机器人领域业务增长强劲,投资者对其长期发展前景持看好态度。
多家机构对Procept Biorobotics也给予了看好评级,平均目标价为103.5美元,较当前股价仍有10%的上涨空间。该公司主要产品AquaBeam手术机器人系统被广泛用于泌尿外科手术,在前列腺增生症等领域潜力巨大,营收有望继续保持快速增长。因此公司获得市场认可度提升,推动当日股价出现大涨表现。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.